000			02363 a2200637 4500
005			20250514072218.0
264		0	_c20040304
008			200403s 0 0 eng d
022			_a0105-4538
024	7		_a10.1034/j.1398-9995.2003.00188.x _2doi
040			_aNLM _beng _cNLM
100	1		_aCurrie, G P
245	0	0	_aEffects of low dose fluticasone/salmeterol combination on surrogate inflammatory markers in moderate persistent asthma. _h[electronic resource]
260			_bAllergy _cJul 2003
300			_a602-7 p. _bdigital
500			_aPublication Type: Comparative Study; Evaluation Study; Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdministration, Inhalation
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAlbuterol _xadministration & dosage
650	0	4	_aAndrostadienes _xadministration & dosage
650	0	4	_aAnti-Asthmatic Agents _xadministration & dosage
650	0	4	_aAsthma _xdrug therapy
650	0	4	_aBeclomethasone _xadministration & dosage
650	0	4	_aBiomarkers _xanalysis
650	0	4	_aBlood Proteins _xdrug effects
650	0	4	_aBronchial Provocation Tests
650	0	4	_aBronchoconstrictor Agents _xadministration & dosage
650	0	4	_aBronchodilator Agents _xadministration & dosage
650	0	4	_aBudesonide _xadministration & dosage
650	0	4	_aChlorofluorocarbons _xadministration & dosage
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aDrug Therapy, Combination
650	0	4	_aEosinophil Granule Proteins
650	0	4	_aEosinophils _xdrug effects
650	0	4	_aFluticasone
650	0	4	_aForced Expiratory Flow Rates _xdrug effects
650	0	4	_aForced Expiratory Volume _xdrug effects
650	0	4	_aHumans
650	0	4	_aMethacholine Chloride _xadministration & dosage
650	0	4	_aMiddle Aged
650	0	4	_aPredictive Value of Tests
650	0	4	_aRibonucleases _xdrug effects
650	0	4	_aSalmeterol Xinafoate
650	0	4	_aSeverity of Illness Index
650	0	4	_aSpirometry
650	0	4	_aSputum _xchemistry
650	0	4	_aTreatment Outcome
700	1		_aSyme-Grant, N J
700	1		_aMcFarlane, L C
700	1		_aCarey, F A
700	1		_aLipworth, B J
773	0		_tAllergy _gvol. 58 _gno. 7 _gp. 602-7
856	4	0	_uhttps://doi.org/10.1034/j.1398-9995.2003.00188.x _zAvailable from publisher's website
999			_c12606295 _d12606295